BIOJECT MEDICAL TECHNOLOGIES, founded in 1985, is a pioneer in the Biotechnology and Health and Wellness sectors. The company has carved a niche with its innovative Needle-Free Injection Therapies, encapsulated by its slogan: "Experience the future of medicine with needle-free injection technology, ensuring fast, precise, and comfortable medication delivery."
Recent activities include a $680.00K Debt Financing investment on 29 October 2013. This investment indicates interest in their cutting-edge technology aimed at enhancing patient experience and medication delivery efficiency. However, details regarding the investors involved remain undisclosed.
While the company’s exact headquarters are unspecified, their enduring presence in the market underscores a longstanding commitment to advancing medical technology. Prospective investors might find BIOJECT a compelling opportunity given its established background and focus on revolutionary medical techniques. However, attention should be given to the near-decade gap since the last recorded investment.
